KURA – kura oncology, inc. (US:NASDAQ)
Stock Stats
News
Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma Transcript [Seeking Alpha]
Kura Oncology Shares Surge Following Positive Kidney Cancer Trial Data [TheStreet.com]
Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib
Kura Oncology (KURA) was upgraded by Lake Street Capital to "strong-buy".
Kura Oncology (KURA) is now covered by Lake Street Capital. They set a "buy" rating on the stock.
Form ARS Kura Oncology, Inc. For: Dec 31
Form DEFA14A Kura Oncology, Inc.
Form DEF 14A Kura Oncology, Inc. For: Jun 04
Form SCHEDULE 13G/A Kura Oncology, Inc. Filed by: VANGUARD GROUP INC
Form 4 Kura Oncology, Inc. For: Mar 23 Filed by: WILSON TROY EDWARD
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.